| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 17/12/19 | | 09:00:06 | 17 Dec 2019 | | | Blocklisting Application | Glaxosmithkline PLC | RNS |
| 13/12/19 | | 16:48:11 | 13 Dec 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 11/12/19 | | 16:57:52 | 11 Dec 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 05/12/19 | | 12:00:05 | 5 Dec 2019 | | | ViiV submits NDA to FDA for fostemsavir | Glaxosmithkline PLC | RNS |
| 04/12/19 | | 17:34:14 | 4 Dec 2019 | | | Emma Walmsley - External Appointment | Glaxosmithkline PLC | RNS |
| 02/12/19 | | 17:52:17 | 2 Dec 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 02/12/19 | | 16:54:47 | 2 Dec 2019 | | | Total Voting Rights | Glaxosmithkline PLC | RNS |
| 26/11/19 | | 15:00:02 | 26 Nov 2019 | | | Block listing Interim Review | Glaxosmithkline PLC | RNS |
| 12/11/19 | | 15:51:15 | 12 Nov 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 08/11/19 | | 16:22:43 | 8 Nov 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 06/11/19 | | 16:36:40 | 6 Nov 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 04/11/19 | | 17:35:56 | 4 Nov 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 01/11/19 | | 17:19:40 | 1 Nov 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 01/11/19 | | 09:53:06 | 1 Nov 2019 | | | Total Voting Rights | Glaxosmithkline PLC | RNS |
| 31/10/19 | | 13:34:41 | 31 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 30/10/19 | | 17:32:45 | 30 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 30/10/19 | | 12:07:45 | 30 Oct 2019 | | | Second Price Monitoring Extn | Glaxosmithkline PLC | RNS |
| 30/10/19 | | 12:02:23 | 30 Oct 2019 | | | Price Monitoring Extension | Glaxosmithkline PLC | RNS |
| 30/10/19 | | 12:00:02 | 30 Oct 2019 | | | 3rd Quarter Results | Glaxosmithkline PLC | RNS |
| 21/10/19 | | 09:00:05 | 21 Oct 2019 | | | GSK divests two travel vaccines to Bavarian Nordic | Glaxosmithkline PLC | RNS |
| 15/10/19 | | 18:00:00 | 15 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 15/10/19 | | 18:00:00 | 15 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 15/10/19 | | 18:00:00 | 15 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 15/10/19 | | 18:00:00 | 15 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 11/10/19 | | 18:34:41 | 11 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 11/10/19 | | 17:10:01 | 11 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 10/10/19 | | 17:18:38 | 10 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 01/10/19 | | 19:18:07 | 1 Oct 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 01/10/19 | | 14:09:37 | 1 Oct 2019 | | | Total Voting Rights | Glaxosmithkline PLC | RNS |
| 30/09/19 | | 08:00:04 | 30 Sept 2019 | | | Data show anti-tumour activity with ICOS agonist | Glaxosmithkline PLC | RNS |
| 30/09/19 | | 08:00:04 | 30 Sept 2019 | | | PRIMA shows Zejula improves PFS in ovarian cancer | Glaxosmithkline PLC | RNS |
| 26/09/19 | | 19:26:09 | 26 Sept 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 17/09/19 | | 18:46:15 | 17 Sept 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 11/09/19 | | 17:30:41 | 11 Sept 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 04/09/19 | | 18:37:31 | 4 Sept 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 04/09/19 | | 13:36:43 | 4 Sept 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 04/09/19 | | 10:33:33 | 4 Sept 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 02/09/19 | | 12:29:03 | 2 Sept 2019 | | | Total Voting Rights | Glaxosmithkline PLC | RNS |
| 23/08/19 | | 08:00:06 | 23 Aug 2019 | | | GSK - positive results from pivotal DREAMM-2 study | Glaxosmithkline PLC | RNS |
| 22/08/19 | | 08:00:13 | 22 Aug 2019 | | | ViiV results positive for every 2 month injection | Glaxosmithkline PLC | RNS |
| 21/08/19 | | 09:00:04 | 21 Aug 2019 | | | GSK submits regulatory file in Japan: Daprodustat | Glaxosmithkline PLC | RNS |
| 12/08/19 | | 16:45:29 | 12 Aug 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 01/08/19 | | 16:30:01 | 1 Aug 2019 | | | EU approval for Nucala self-administration | Glaxosmithkline PLC | RNS |
| 01/08/19 | | 15:10:01 | 1 Aug 2019 | | | Total Voting Rights | Glaxosmithkline PLC | RNS |
| 30/07/19 | | 16:35:04 | 30 Jul 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
| 29/07/19 | | 08:00:06 | 29 Jul 2019 | | | ViiV submits cabotegravir to EMA for HIV injection | Glaxosmithkline PLC | RNS |
| 24/07/19 | | 19:01:32 | 24 Jul 2019 | | | Director/PDMR Shareholding | Glaxosmithkline PLC | RNS |
